1. Home
  2. RGEN vs CAVA Comparison

RGEN vs CAVA Comparison

Compare RGEN & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$179.65

Market Cap

10.0B

Sector

Health Care

ML Signal

N/A

Logo CAVA Group Inc.

CAVA

CAVA Group Inc.

N/A

Current Price

$54.47

Market Cap

10.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
RGEN
CAVA
Founded
1981
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
10.6B
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
RGEN
CAVA
Price
$179.65
$54.47
Analyst Decision
Buy
Buy
Analyst Count
22
28
Target Price
★ $189.70
$82.75
AVG Volume (30 Days)
880.1K
★ 3.2M
Earning Date
10-27-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 286.96
N/A
EPS
0.24
★ 0.39
Revenue
$141,236,000.00
★ $1,179,664,000.00
Revenue This Year
$12.04
$27.54
Revenue Next Year
$17.80
$20.84
P/E Ratio
$805.46
★ $136.68
Revenue Growth
★ 35.10
22.41
52 Week Low
$100.99
$43.41
52 Week High
$198.87
$98.79

Technical Indicators

Market Signals
Indicator
RGEN
CAVA
Relative Strength Index (RSI) 63.35 41.24
Support Level $159.22 $49.68
Resistance Level N/A $55.41
Average True Range (ATR) 6.58 1.97
MACD 0.98 0.59
Stochastic Oscillator 75.63 63.19

Price Performance

Historical Comparison
RGEN
CAVA

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

About CAVA CAVA Group Inc.

Cava Group Inc owns and operates a chain of restaurants. It operates a Mediterranean-inspired fast-casual restaurant brand offering menu items. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: i) CAVA: It includes the operations of all company-owned CAVA restaurants, and ii) CAVA Foods: It includes the production of dips, spreads, and certain dressing bases used in CAVA restaurants as well as sales from the Company's consumer packaged goods business. The company generates the majority of its revenue from the CAVA segment.

Share on Social Networks: